In the discovery stage, IgA and IgG antibody responses to 646 viral proteins from 23 viruses (Fig. 1B) were measured using NAPPA microarrays with pooled serum from patients with NPC or controls (Fig. 1C). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.